-
Encouraging Data on MNKD's Afrezza - Analyst Blog
Wednesday, June 30, 2010 - 10:37am | 583Recently, MannKind Corp. (MNKD) announced encouraging data on its inhaled insulin candidate, Afrezza, from a two-year study in patients suffering from type II diabetes. The efficacy data was presented at the 70th Annual Scientific Sessions of the American Diabetes Association held in Orlando. ...
-
Citigroup Initiates Hold Rating on Waters Corp. (WAT)
Wednesday, June 30, 2010 - 9:59am | 261Citigroup is out with a research report this morning, where it initiates a Hold rating on shares of Waters Corp. (NYSE: WAT); it has a $78.00 price target on the stock. The Citigroup analysts said, “While we have a positive bias towards companies with market leadership and proven tech. innovation...
-
Citigroup Initiates Buy Rating on Thermo Fisher (TMO)
Wednesday, June 30, 2010 - 9:58am | 264Citigroup is out with a research report this morning, where it initiates a Buy rating on shares of Thermo Fisher Scientific Inc. (NYSE: TMO); it has a $63.00 price target on the stock. The Citigroup analysts said, “Formed in 2006 from the merger between Thermo Electron and Fisher Scientific, TMO...
-
Citigroup Initiates Hold Rating on Illumina Inc. (ILMN)
Wednesday, June 30, 2010 - 9:40am | 281Citigroup is out with a research report this morning, where it initiated a Hold rating on shares of Illumina Inc. (NASDAQ: ILMN); it has a $52.00 price target on the stock. The Citigroup analysts said, “Illumina is a life sciences tools company that has clear market leadership and proven...
-
Top 4 Stocks In The Drug Delivery Industry With The Highest Gross Margin (BVF, ALKS, MTXX, NKTR)
Friday, June 25, 2010 - 6:01am | 151Below are the top drug delivery stocks on the NYSE and the NASDAQ in terms of gross margin. The trailing-twelve-month gross margin at Biovail Corporation (NYSE: BVF) stands at 73.22%. BVF’s quarterly revenue growth is 26.70% y/y. The trailing-twelve-month gross margin at Alkermes Inc (NASDAQ: ALKS...
-
Mid-Day Market Movers (ADG, MIPI, FCVA, GENE)
Thursday, June 24, 2010 - 10:44am | 147The Allied Defense Group Inc (AMEX: ADG) soared 51.52% to $4.00 by 10:02 am. Chemring has agreed to purchase most of ADG's assets for $59.6 million in cash. Molecular Insight Pharmaceuticals Inc (NASDAQ: MIPI) climbed 35.63% to $2.17. MIPI has presented positive data from Azedra Phase 2a clinical...
-
Calls Sold on Exelixis (EXEL)
Wednesday, June 23, 2010 - 2:51pm | 135Shares of Exelixis Inc. (NASDAQ: EXEL) are higher on the session by 3.01%, currently trading at $3.77. The stock has been running lower and lower over the past six months; it is off more than 50% during that time period. Options traders believe that any rally in EXEL will be short-lived. The...
-
Benzinga’s Top Pre-Market Gainers (AIPC, EXEL, CRUS, GXDX)
Monday, June 21, 2010 - 8:35am | 170American Italian Pasta Company (NASDAQ: AIPC) soared 26.29% to $52.7 in the pre-market session. AIPC is about to be acquired by snacks company Ralcorp Holdings Inc (NYSE: RAH) in an all cash deal valued at $1.2 billion, or $53 a share. Exelixis Inc (NASDAQ: EXEL) added 4.8% to $4.8 in pre-market...
-
Auriga Reiterates Buy Rating on eResearch (ERES)
Monday, June 21, 2010 - 8:14am | 134Following meetings with eResearch (NASDAQ: ERES) management, Auriga reiterated its Buy rating and $10 price target on the company. Auriga is "increasingly confident in the prospects for eResearch" after the acquisition of CRS. CRS is the market leader in respiratory core lab services for clinical...
-
Impressive Bounce 06-17-2010
Thursday, June 17, 2010 - 6:35pm | 716Cusick’s Corner An impressive bounce occurred today after the market had been pounded down, resulting in all the indices finishing the day on the positive side. When you see moves like this, you want to see the market retake support, 1110 on the ESU10. Do not forget that tomorrow is expiration, a...
-
Calendar Spread Trades in Sequenom (SQNM)
Thursday, June 17, 2010 - 12:58pm | 143Shares of Sequenom Inc. (NASDAQ: SQNM) are lower on the session by 2.99%, currently trading at $6.16. The stock has been moving largely sideways for the past three months, hugging the $6.00 level. It appears that one trader is betting the stock continues to move sideways for the next few months....
-
ICON Receives ‘Buy’ Rating (GS, ICLR, PPDI)
Wednesday, June 16, 2010 - 4:24pm | 145Goldman Sachs (NYSE: GS) has released its report covering the Healthcare Services segment. Goldman (GS) has chosen ICON (NASDAQ: ICLR) and PAREXEL as its top picks. ICON's CFO stated that he expects solid business wins in 1Q to be a “multi-quarter phenomenon’ He also said that current operating...
-
Late Day Short-Covering 06-11-2010
Friday, June 11, 2010 - 6:31pm | 787Cusick’s Corner Today’s report of an unexpected drop in May retail sales was balanced later by an unexpected increase in consumer sentiment. Today’s trading range was relatively tight, volume was light, but all major stock indices closed higher possibly due to some end-of-day short covering. The...
-
Auriga Upgrades Sequenom To Buy, Shares Surge (SQNM)
Friday, June 11, 2010 - 3:41pm | 153Auriga released a research report today upgrading shares of Sequenom (NASDAQ: SQNM) to Buy with a $9 price target. The company is developing a non-invasive prenatal diagnostic test for Trisomy 21 (T-21, Down Syndrome). The analysts wrote that "after reviewing recent literature and discussions with...
-
MannKind Presents Positive Data - Analyst Blog
Friday, June 11, 2010 - 2:45pm | 371MannKind Corp. (MNKD) provided results on its inhaled insulin candidate, Afrezza. It was observed that the combination of Afrezza and basal insulin was non-inferior to the combination of standard therapy insulin lispro (rapid acting insulin) and basal insulin in reducing HbA1c levels in patients...